Transformational and accretive acquisition adds significant scale to INVO's current operations
Contributes over $5 million in incremental annual revenue as well as positive net income and cash flows
Read more at prnewswire.comWe've received your inquiry. A specialist will reach out within 1 business day.
Start overAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Transformational and accretive acquisition adds significant scale to INVO's current operations
Contributes over $5 million in incremental annual revenue as well as positive net income and cash flows
Read more at prnewswire.com| Symbol | Last | Chg | %Chg |
|---|---|---|---|
| INVO | 0.8330 | -0.0250 | -2.91% |
| Invo Bioscience Inc | |||